Adaptive immunity maintains occult cancer in an equilibrium state (original) (raw)
Shankaran, V. et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature410, 1107–1111 (2001) ArticleADSCASPubMed Google Scholar
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J. & Schreiber, R. D. Cancer immunoediting: from immunosurveillance to tumor escape. Nature Immunol.3, 991–998 (2002) ArticleCAS Google Scholar
Street, S. E., Trapani, J. A., MacGregor, D. & Smyth, M. J. Suppression of lymphoma and epithelial malignancies effected by interferon γ. J. Exp. Med.196, 129–134 (2002) ArticleCASPubMedPubMed Central Google Scholar
Smyth, M. J. et al. NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer. J. Exp. Med.200, 1325–1335 (2004) ArticleCASPubMedPubMed Central Google Scholar
Dunn, G. P., Old, L. J. & Schreiber, R. D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity21, 137–148 (2004) ArticleCASPubMed Google Scholar
Dunn, G. P. et al. A critical function for type I interferons in cancer immunoediting. Nature Immunol.6, 722–729 (2005) ArticleCAS Google Scholar
Dunn, G. P., Old, L. J. & Schreiber, R. D. The three Es of cancer immunoediting. Annu. Rev. Immunol.22, 329–360 (2004) ArticleCASPubMed Google Scholar
Smyth, M. J., Dunn, G. P. & Schreiber, R. D. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv. Immunol.90, 1–50 (2006) ArticleCASPubMed Google Scholar
Dunn, G. P., Koebel, C. M. & Schreiber, R. D. Interferons, immunity and cancer immunoediting. Nature Rev. Immunol.6, 836–848 (2006) ArticleCAS Google Scholar
MacKie, R. M., Reid, R. & Junor, B. Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. N. Engl. J. Med.348, 567–568 (2003) ArticlePubMed Google Scholar
Qin, Z., Kim, H. J., Hemme, J. & Blankenstein, T. Inhibition of methylcholanthrene-induced carcinogenesis by an interferon γ receptor-dependent foreign body reaction. J. Exp. Med.195, 1479–1490 (2002) ArticleCASPubMedPubMed Central Google Scholar
Brown, D. C. & Gatter, K. C. Ki67 protein: the immaculate deception? Histopathology40, 2–11 (2002) ArticleCASPubMed Google Scholar
Bullwinkel, J. et al. Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J. Cell. Physiol.206, 624–635 (2006) ArticleCASPubMed Google Scholar
Weinhold, K. J., Goldstein, L. T. & Wheelock, E. F. Tumour-dormant states established with L5178Y lymphoma cells in immunised syngeneic murine hosts. Nature270, 59–61 (1977) ArticleADSCASPubMed Google Scholar
Siu, H., Vitetta, E. S., May, R. D. & Uhr, J. W. Tumor dormancy. I. Regression of BCL1 tumor and induction of a dormant tumor state in mice chimeric at the major histocompatibility complex. J. Immunol.137, 1376–1382 (1986) CASPubMed Google Scholar
Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science313, 1960–1964 (2006) ArticleADSCASPubMed Google Scholar
Ohtani, H. Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun.7, 4–12 (2007) PubMedPubMed Central Google Scholar
Sato, E. et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl Acad. Sci. USA102, 18538–18543 (2005) ArticleADSCASPubMedPubMed Central Google Scholar
Sakr, W. A. & Partin, A. W. Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia. Urology57, 115–120 (2001) ArticleCASPubMed Google Scholar
Welch, H. G. & Black, W. C. Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann. Intern. Med.127, 1023–1028 (1997) ArticleCASPubMed Google Scholar
Mutter, G. L. et al. Molecular identification of latent precancers in histologically normal endometrium. Cancer Res.61, 4311–4314 (2001) CASPubMed Google Scholar
Bach, P. B. et al. Computed tomography screening and lung cancer outcomes. J. Am. Med. Assoc.297, 953–961 (2007) ArticleCAS Google Scholar
Lin, W. W. & Karin, M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest.117, 1175–1183 (2007) ArticleCASPubMedPubMed Central Google Scholar
Dialynas, D. P. et al. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol. Rev.74, 29–56 (1983) ArticleCASPubMed Google Scholar
Cobbold, S. P., Jayasuriya, A., Nash, A., Prospero, T. D. & Waldmann, H. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo . Nature312, 548–551 (1984) ArticleADSCASPubMed Google Scholar
Schreiber, R. D., Hicks, L. J., Celada, A., Buchmeier, N. A. & Gray, P. W. Monoclonal antibodies to murine γ-interferon which differentially modulate macrophage activation and antiviral activity. J. Immunol.134, 1609–1618 (1985) CASPubMed Google Scholar
Ho, E. L. et al. Costimulation of multiple NK cell activation receptors by NKG2D. J. Immunol.169, 3667–3675 (2002) ArticleCASPubMed Google Scholar
Koo, G. C. & Peppard, J. R. Establishment of monoclonal anti-Nk-1.1 antibody. Hybridoma3, 301–303 (1984) ArticleCASPubMed Google Scholar
Kayagaki, N. et al. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J. Immunol.163, 1906–1913 (1999) CASPubMed Google Scholar
Wysocka, M. et al. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol.25, 672–676 (1995) ArticleCASPubMed Google Scholar
Dunn, G. P. et al. A critical function for type I interferons in cancer immunoediting. Nature Immunol.6, 722–729 (2005) ArticleCAS Google Scholar
Smyth, M. J. et al. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med.4, 661–668 (2000) Article Google Scholar
Shankaran, V. et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature410, 1107–1111 (2001) ArticleADSCASPubMed Google Scholar